TWST – twist bioscience corporation (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

TWST

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/14

04:41 pm

twst

Rating for TWST

Low Report

Rating for TWST

Report

4/14

04:41 pm

twst

Rating for TWST

Low Report

Rating for TWST

Report

4/14

07:13 am

twst

Twist Bioscience (TWST) had its "overweight" rating reaffirmed by Barclays PLC.

High Report

Twist Bioscience (TWST) had its "overweight" rating reaffirmed by Barclays PLC.

Report

4/6

01:40 pm

twst

Rating for TWST

Low Report

Rating for TWST

Report

3/30

11:20 am

twst

Rating for TWST

Low Report

Rating for TWST

Report

3/30

11:20 am

twst

Rating for TWST

Low Report

Rating for TWST

Report

2/3

09:19 am

twst

Rating for TWST

Low Report

Rating for TWST

Report

2/3

09:11 am

twst

Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.

Low Report

Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.

Report

2/3

09:11 am

twst

Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.

Low Report

Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.

Report

2/3

08:35 am

twst

Rating for TWST

Low Report

Rating for TWST

Report

2/3

08:35 am

twst

Rating for TWST

Low Report

Rating for TWST

Report

1/26

11:39 am

twst

Rating for TWST

Low Report

Rating for TWST

Report

1/26

11:39 am

twst

Rating for TWST

Low Report

Rating for TWST

Report

1/26

10:02 am

twst

Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Guggenheim.

Low Report

Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Guggenheim.

Report

1/26

10:02 am

twst

Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Guggenheim.

Low Report

Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Guggenheim.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.